Patents by Inventor Jürgen Wruss
Jürgen Wruss has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10744194Abstract: Described herein are processes for purifying infectious Zika virus particles and uses of protamine in such processes.Type: GrantFiled: December 23, 2016Date of Patent: August 18, 2020Assignee: Valneva Austria GmbHInventors: Jana Barbero Calzado, Mario Nebenführ, Robert Schlegl, Michael Weber, Jürgen Wruss
-
Publication number: 20190008945Abstract: Described herein are improved purification methods for Zika virus vaccines and compositions. Also described are Zika vaccines and methods of producing and administering said Zika vaccines to subjects in need thereof.Type: ApplicationFiled: December 23, 2016Publication date: January 10, 2019Applicant: Valneva Austria GmbHInventors: Jana Barbero Calzado, Mario Nebenführ, Robert SchlegI, Michael Weber, Jürgen Wruss
-
Publication number: 20180371027Abstract: Described herein are Zika virus vaccines and compositions and methods of producing and administering said vaccines to subjects in need thereof.Type: ApplicationFiled: December 23, 2016Publication date: December 27, 2018Applicant: Valneva Austria GmbHInventors: Jana BARBERO CALZADO, Mario NEBENFÜHR, Robert SCHLGEL, Michael WEBER, Jürgen WRUSS
-
Publication number: 20180369359Abstract: Described herein are improved purification methods for virus vaccines and compositions. Also described are Zika, Chikungunya, dengue and yellow fever vaccines and methods of producing and administering said vaccines to subjects in need thereof.Type: ApplicationFiled: December 23, 2016Publication date: December 27, 2018Applicant: Valneva SEInventors: Jana Barbero Calzado, Mario Nebenführ, Robert Schlegl, Michael Weber, Jürgen Wruss
-
Publication number: 20180362937Abstract: Described herein are processes for purifying infectious virus particles and uses of protamine in such processes.Type: ApplicationFiled: December 23, 2016Publication date: December 20, 2018Applicant: Valneva SEInventors: Jana Barbero Calzado, Mario Nebenführ, Robert Schlegl, Michael Weber, Jürgen Wruss
-
Publication number: 20180362936Abstract: Described herein are processes for purifying infectious Zika virus particles and uses of protamine in such processes.Type: ApplicationFiled: December 23, 2016Publication date: December 20, 2018Applicant: Valneva Austria GmbHInventors: Jana Barbero Calzado, Mario Nebenführ, Robert Schlegl, Michael Weber, Jürgen Wruss
-
Patent number: 9913898Abstract: The invention relates to means and methods for preparing aqueous composition comprising aluminum and a protein said composition comprising less than 700 ppm heavy metal on the basis of weight with respect to the aluminum content. The invention further relates to aqueous compositions comprising a protein and an aluminum-salt, said composition comprising less than 350 ppb heavy metal based on the weight of the aqueous composition.Type: GrantFiled: July 29, 2016Date of Patent: March 13, 2018Assignee: Valneva Austria GmbHInventors: Robert Schlegl, Michael Möhlen, Jürgen Wruss, Michael Weber
-
Patent number: 9895437Abstract: The invention relates to means and methods for preparing aqueous composition comprising aluminum and a protein said composition comprising less than 700 ppm heavy metal on the basis of weight with respect to the aluminum content. The invention further relates to aqueous compositions comprising a protein and an aluminum-salt, said composition comprising less than 350 ppb heavy metal based on the weight of the aqueous composition.Type: GrantFiled: April 18, 2012Date of Patent: February 20, 2018Assignee: Valneva Austria GmbHInventors: Robert Schlegl, Michael Möhlen, Jürgen Wruss, Michael Weber
-
Patent number: 9884115Abstract: The invention relates to means and methods for preparing aqueous composition comprising aluminium and a protein said composition comprising less than 700 ppm heavy metal on the basis of weight with respect to the aluminium content. The invention further relates to aqueous compositions comprising a protein and an aluminium-salt, said composition comprising less than 350 ppb heavy metal based on the weight of the aqueous composition.Type: GrantFiled: October 2, 2015Date of Patent: February 6, 2018Assignee: Valneva Austria GmbHInventors: Robert Schlegl, Michael Möhlen, Jürgen Wruss, Michael Weber
-
Publication number: 20170296656Abstract: The invention relates to means and methods for preparing aqueous composition comprising aluminium and a protein said composition comprising less than 700 ppm heavy metal on the basis of weight with respect to the aluminium content. The invention further relates to aqueous compositions comprising a protein and an aluminium-salt, said composition comprising less than 350 ppb heavy metal based on the weight of the aqueous composition.Type: ApplicationFiled: March 27, 2017Publication date: October 19, 2017Applicant: Valneva Austria GmbHInventors: ROBERT SCHLEGL, Michael Möhlen, Jürgen Wruss, Michael Weber
-
Publication number: 20160324959Abstract: The invention relates to means and methods for preparing aqueous composition comprising aluminium and a protein said composition comprising less than 700 ppm heavy metal on the basis of weight with respect to the aluminium content. The invention further relates to aqueous compositions comprising a protein and an aluminium-salt, said composition comprising less than 350 ppb heavy metal based on the weight of the aqueous composition.Type: ApplicationFiled: July 29, 2016Publication date: November 10, 2016Applicant: Valneva Austria GmbHInventors: ROBERT SCHLEGL, Michael Möhlen, Jürgen Wruss, Michael Weber
-
Publication number: 20160114033Abstract: The invention relates to means and methods for preparing aqueous composition comprising aluminium and a protein said composition comprising less than 700 ppm heavy metal on the basis of weight with respect to the aluminium content. The invention further relates to aqueous compositions comprising a protein and an aluminium-salt, said composition comprising less than 350 ppb heavy metal based on the weight of the aqueous composition.Type: ApplicationFiled: October 2, 2015Publication date: April 28, 2016Applicant: Valneva Austria GmbHInventors: Robert Schlegl, Michael Möhlen, Jürgen Wruss, Michael Weber
-
Patent number: 9248180Abstract: The invention discloses pharmaceutical compositions in liquid form comprising a peptide with the amino acid sequence KLKL5KLK and an oligodeoxynucleotide with the nucleic acid sequence (dIdC)13 and wherein the peptide and the oligodeoxynucleotide are present as sterile-filterable nanoparticles in the composition, thereby forming a suspension, characterized in that the mean particle size of the solid particles is less than 1 ?m.Type: GrantFiled: April 22, 2014Date of Patent: February 2, 2016Assignee: Valneva Austria GmbHInventors: Benjamin Wizel, Karin Riedl, Karen Lingnau, Ursula Schlosser, Jürgen Wruss, Robert Schlegl, Michael Weber, Christoph Reinisch, Ljubomir Paucz, Christoph Klade, Jee Loon Look, Christian Ruiz, Robert Seid
-
Publication number: 20150216967Abstract: The invention discloses pharmaceutical compositions in liquid form comprising a peptide with the amino acid sequence KLKL5KLK and an oligodeoxynucleotide with the nucleic acid sequence (dIdC)13 and wherein the peptide and the oligodeoxynucleotide are present as sterile-filterable nanoparticles in the composition, thereby forming a suspension, characterized in that the mean particle size of the solid particles is less than 1 ?m.Type: ApplicationFiled: April 22, 2014Publication date: August 6, 2015Applicant: Valneva Austria GmbHInventors: Benjamin Wizel, Karin Riedl, Karen Lingnau, Ursula Schlosser, Jürgen Wruss, Robert Schlegl, Michael Weber, Christoph Reinisch, Ljubomir Paucz, Christoph Klade, Jee Loon Look, Christian Ruiz, Robert Seid
-
Patent number: 8765148Abstract: The invention discloses pharmaceutical compositions in liquid form comprising a peptide with the amino acid sequence KLKL5KLK and an oligodeoxynucleotide with the nucleic acid sequence (dIdC)13 and wherein the peptide and the oligodeoxynucleotide are present as sterile-filterable nanoparticles in the composition, thereby forming a suspension, characterized in that the mean particle size of the solid particles is less than 1 ?m.Type: GrantFiled: February 21, 2011Date of Patent: July 1, 2014Assignee: Valneva Austria GmbHInventors: Benjamin Wizel, Karin Riedl, Karen Lingnau, Ursula Schlosser, Jürgen Wruss, Robert Schlegl, Michael Weber, Christoph Reinisch, Ljubomir Paucz, Christoph Klade, Jee Loon Look, Christian Ruiz, Robert Seid
-
Publication number: 20120308618Abstract: The invention discloses pharmaceutical compositions in liquid form comprising a peptide with the amino acid sequence KLKL5KLK and an oligodeoxynucleotide with the nucleic acid sequence (dIdC)13 and wherein the peptide and the oligodeoxynucleotide are present as sterile-filterable nanoparticles in the composition, thereby forming a suspension, characterized in that the mean particle size of the solid particles is less than 1 ?m.Type: ApplicationFiled: February 21, 2011Publication date: December 6, 2012Applicant: Intercell AGInventors: Benjamin Wizel, Karin Riedl, Karen Lingnau, Ursula Schlosser, Jürgen Wruss, Robert Schlegl, Michael Weber, Christoph Reinisch, Ljubomir Paucz, Christoph Klade, Jee Loon Look, Christian Ruiz, Robert Seid